308 related articles for article (PubMed ID: 19139364)
1. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
Resnick SM; Espeland MA; Jaramillo SA; Hirsch C; Stefanick ML; Murray AM; Ockene J; Davatzikos C
Neurology; 2009 Jan; 72(2):135-42. PubMed ID: 19139364
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.
Coker LH; Hogan PE; Bryan NR; Kuller LH; Margolis KL; Bettermann K; Wallace RB; Lao Z; Freeman R; Stefanick ML; Shumaker SA
Neurology; 2009 Jan; 72(2):125-34. PubMed ID: 19139363
[TBL] [Abstract][Full Text] [Related]
3. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
[TBL] [Abstract][Full Text] [Related]
4. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
Coker LH; Espeland MA; Rapp SR; Legault C; Resnick SM; Hogan P; Gaussoin S; Dailey M; Shumaker SA
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):304-10. PubMed ID: 19932751
[TBL] [Abstract][Full Text] [Related]
6. Brain volumes, cognitive impairment, and conjugated equine estrogens.
Espeland MA; Tindle HA; Bushnell CA; Jaramillo SA; Kuller LH; Margolis KL; Mysiw WJ; Maldjian JA; Melhem ER; Resnick SM;
J Gerontol A Biol Sci Med Sci; 2009 Dec; 64(12):1243-50. PubMed ID: 19729392
[TBL] [Abstract][Full Text] [Related]
7. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies.
Coker LH; Espeland MA; Hogan PE; Resnick SM; Bryan RN; Robinson JG; Goveas JS; Davatzikos C; Kuller LH; Williamson JD; Bushnell CD; Shumaker SA;
Neurology; 2014 Feb; 82(5):427-34. PubMed ID: 24384646
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR
Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666
[TBL] [Abstract][Full Text] [Related]
10. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
12. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
[TBL] [Abstract][Full Text] [Related]
13. Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.
Armstrong NM; Espeland MA; Chen JC; Masaki K; Wactawski-Wende J; Li W; Gass MLS; Stefanick ML; Manson JE; Deal JA; Rapp SR; Lin FR; Resnick SM
J Gerontol A Biol Sci Med Sci; 2020 Feb; 75(3):537-544. PubMed ID: 31326978
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Maki PM; Henderson VW
Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
[TBL] [Abstract][Full Text] [Related]
15. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
Manson JE; Aragaki AK; Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Chlebowski RT; Howard BV; Thomson CA; Margolis KL; Lewis CE; Stefanick ML; Jackson RD; Johnson KC; Martin LW; Shumaker SA; Espeland MA; Wactawski-Wende J;
JAMA; 2017 Sep; 318(10):927-938. PubMed ID: 28898378
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen with and without progestin on urinary incontinence.
Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
[TBL] [Abstract][Full Text] [Related]
17. Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
Espeland MA; Brinton RD; Hugenschmidt C; Manson JE; Craft S; Yaffe K; Weitlauf J; Vaughan L; Johnson KC; Padula CB; Jackson RD; Resnick SM;
Diabetes Care; 2015 Dec; 38(12):2316-24. PubMed ID: 26486190
[TBL] [Abstract][Full Text] [Related]
18. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
19. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
[TBL] [Abstract][Full Text] [Related]
20. Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.
Panay N; Nappi RE; Stute P; Palacios S; Paszkowski T; Kagan R; Archer DF; Héroux J; Boolell M
Maturitas; 2023 Jun; 172():23-31. PubMed ID: 37084589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
